Search hospitals

>

Missouri

>

Cape Girardeau

Southeast Cancer Center

Claim this profile

Cape Girardeau, Missouri 63703

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Cancer

Conducts research for Prostate Cancer

317 reported clinical trials

3 medical researchers

Photo of Southeast Cancer Center in Cape GirardeauPhoto of Southeast Cancer Center in Cape Girardeau

Summary

Southeast Cancer Center is a medical facility located in Cape Girardeau, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Southeast Cancer Center is involved with conducting 317 clinical trials across 424 conditions. There are 3 research doctors associated with this hospital, such as Bryan A. Faller, Jay W Carlson, and James L. Wade.

Area of expertise

1

Breast Cancer

Global Leader

Southeast Cancer Center has run 53 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive
2

Lung Cancer

Global Leader

Southeast Cancer Center has run 51 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Southeast Cancer Center

Bladder Cancer

Prostate Cancer

Lung Cancer

Esophageal cancer

Cancer

Breast Cancer

Multiple Myeloma

Kidney Cancer

Melanoma

Bladder Carcinoma

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Image of trial facility.

Immunotherapy + Targeted Therapy

for Genitourinary Cancers

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.

Recruiting

1 award

Phase 2

21 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Southeast Cancer Center?

Where is Southeast Cancer Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Southeast Cancer Center accept?

What awards or recognition has Southeast Cancer Center received?